S.E.C. v. JOHNSTON

Civil Action No. 16-10607-NMG.

310 F.Supp.3d 265 (2018)

SECURITIES AND EXCHANGE COMMISSION, Plaintiff v. David JOHNSTON, Defendant.

United States District Court, D. Massachusetts.

Signed April 19, 2018.

Editors Note
Applicable Law: 12 U.S.C. § 22
Cause: 12 U.S.C. § 22 Securities Fraud
Nature of Suit: 850 Securities / Commodities
Source: PACER


Attorney(s) appearing for the Case

Eric A. Forni , Richard Mann Harper, II , Rachel E. Hershfang , Susan C. Anderson , United States Securities and Exchange Commission, Boston, MA, for Plaintiff.

John F. Sylvia , Andrew Nathanson , Emily K. Musgrave , Jessica C. Sergi , Julia M. Ong , Kerime S. Akoglu , Kevin C. Mortimer , Matthew D. Levitt , Rebecca D. Raphaelson , Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC, Boston, MA, for Defendant.


MEMORANDUM & ORDER

This case arises out of the development of a cancer drug by AVEO Pharmaceuticals, Inc. ("AVEO"). The Securities and Exchange Commission ("the SEC") alleges that AVEO, its chief executive officer Tuan Ha-Ngoc ("Ha-Ngoc"), chief financial officer David Johnston ("Johnston...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases